Isolation of binding proteins with high affinity to ligands

Details Isolation of binding proteins with high affinity to ligands Isolation of binding proteins with high affinity to ligands

2011-01-18

2011-01-18

Navarro, Mark (Department: 1645)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S004000, C435S183000

Reexamination Certificate

active

07871796

ABSTRACT:
The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating binding proteins capable of binding small molecules and peptides via “display-less” library screening. In the technique, libraries of candidate binding proteins, such as antibody sequences, are expressed in soluble form in the periplasmic space of gram negative bacteria, such asEscherichia coli, and are mixed with a labeled ligand. In clones expressing recombinant polypeptides with affinity for the ligand, the concentration of the labeled ligand bound to the binding protein is increased and allows the cells to be isolated from the rest of the library. Where fluorescent labeling of the target ligand is used, cells may be isolated by fluorescence activated cell sorting (FACS). The approach is more rapid than prior art methods and avoids problems associated with the surface-expression of ligand fusion proteins employed with phage display.

REFERENCES:
patent: 5160974 (1992-11-01), Siegel et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5348867 (1994-09-01), Georgiou et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5648237 (1997-07-01), Carter
patent: 5656015 (1997-08-01), Young
patent: 5744314 (1998-04-01), Menzel et al.
patent: 5759810 (1998-06-01), Honjo et al.
patent: 5780279 (1998-07-01), Matthews et al.
patent: 5824520 (1998-10-01), Mulligan-Kehoe
patent: 5837500 (1998-11-01), Ladner et al.
patent: 5866344 (1999-02-01), Georgiou
patent: 5871907 (1999-02-01), Winter et al.
patent: 5922545 (1999-07-01), Mattheakis et al.
patent: 5955604 (1999-09-01), Tsien et al.
patent: 6001823 (1999-12-01), Hultgren et al.
patent: 6004940 (1999-12-01), Marasco et al.
patent: 6248904 (2001-06-01), Zhang et al.
patent: 6335178 (2002-01-01), Weiner et al.
patent: 6335198 (2002-01-01), delCardayre et al.
patent: 6335429 (2002-01-01), Cai et al.
patent: 6342611 (2002-01-01), Weber et al.
patent: 6352859 (2002-03-01), delCardayre et al.
patent: 6379964 (2002-04-01), del Cardayre et al.
patent: 6528311 (2003-03-01), delCardayre et al.
patent: 6548249 (2003-04-01), Anderson et al.
patent: 6548632 (2003-04-01), Anderson et al.
patent: 6562617 (2003-05-01), Anderson et al.
patent: 6716631 (2004-04-01), delCardayre et al.
patent: 6916474 (2005-07-01), Harvey et al.
patent: 7033781 (2006-04-01), Short
patent: 7083945 (2006-08-01), Chen et al.
patent: 7094571 (2006-08-01), Harvey et al.
patent: 7611866 (2009-11-01), Georgiou et al.
patent: 2002/0090666 (2002-07-01), Fritz et al.
patent: 2005/0260736 (2005-11-01), Georgiou et al.
patent: 2006/0029947 (2006-02-01), Georgiou et al.
patent: 2007/0099267 (2007-05-01), Harvey et al.
patent: 177343 (1986-04-01), None
patent: WO 98/49286 (1998-11-01), None
patent: WO 99/60096 (1999-11-01), None
patent: WO 02/22861 (2002-03-01), None
patent: WO 02/34886 (2002-05-01), None
patent: WO 2005/019409 (2005-03-01), None
patent: WO 2005/095988 (2005-10-01), None
Streeter, John G. Journal of General Microbiology, 1989, vol. 135, pp. 3477-3484, Analysis of Periplasmic Enzymes in Intact Cultured Bacteria and Bacteroids ofBradyrhizobium japonicumand Rhizobium leguminosarum biovar phaseoli.
Swiss-Prot Accession No. C6B352.
Martinez, Michael B et al, Biochemistry, vol. 35, 1996, pp. 1179-1186, Accurate Kinetic Modeling of Alkaline Phosphatase in theEscherichia coliPeriplasm: Implication sfor Enzyme Properties and Substrate Diffusion.
Swiss-Prot Accession No. P00634.
Ames,J. Bioenergetics and Biomembranes, 20:1-17, 1988.
Boder and Wittrup, “Yeast surface display for screening combinatorial polypeptide libraries,”Nature Biotechnology, 15:553-557, 1997.
Boeke et al, “Effects of Bacteriophage f1 Gene III Protein on the Host Cell Membrane,”Mol. Gen. Genet., 186:185-192, 1982.
Bradbury, “Selecting by microdialysis,”Nature Biotechnology, 19:528-529, 2001.
Buchner and Rudolph, “Renaturation, purification, and characterization of recombinant Fab-fragments produced inEscherichia coli,” Enzyme Microb. Technol, 9(2):157-162, 1991.
Bukau et al.,J Bacteriology, 163:61-68, 1985.
Burioni et al., “A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries,”Res. Virol., 149:327-330, 1998.
Burman et al., “Murein and the Outer Penetration Barrier ofEscherichia coliK-12,Proteus mirabilis, andPseudomonas aeruginosa,”J Bacteriol., 112(3):1364-1374, 1972.
Chen et al., “Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS),”Nature Biotechnology, 19:537-542, 2001.
Chowdhury and Pastan, “Improving antibody affinity by mimicking somatic hypermutation in vitro,”Nat. Biotech., 17:568-572, 1999.
Coia et al., “Use of mutator cells as a means for increasing production levels of a recombinant antibody directed against Hepatitis B,”Gene201:203-209, 1997.
Dall'Acqua and Carter, “Antibody engineering,”Curr. Opin. Struct. Biol., 8:443-450, 1998.
Danese and Silhavy, “Targeting and assembly of periplasmic and outer-membrane proteins inEscherichia coli,” Annu. Rev. Genet., 32:59-94, 1998.
Daugherty et al., “Development of an optimized expression system for the screening of antibody libraries displayed on theEscherichia colisurface,” Prot. Eng., 12:613-620, 1999.
Daugherty et al., “Flow cytometric screening of cell-based libraries,”J Immunol. Methods. 243:211-227, 2000.
De Haard A et al., “A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies,”J. Biol. Chem., 274:18218-18230, 1999.
De Wildt et al., “Antibody arrays for high-throughput screening of antibody—antigen interactions,”Nat. Biotechnol. 18:989-994, 2000.
Decad and Nikaido, “Outer Membrane of Gram-Negative Bacteria, XII Molecular-Sieving Function of Cell Wall,”J. Bacteriol, 128:325-336, 1976.
Deng et al., “Basis for selection of improved carbohydrate-binding single-chain antibodies from synthetic gene libraries,”Proc. Natl. Acad. Sci. USA. 92:4992-4996, 1995.
Deng et al., “Selection of Antibody Single-chain Variable Fragments with Improved Carbohydrate Binding by Phage Display,”J Biol. Chem., 269:9533-9538, 1994.
Duenas and Borrebaeck, “Clonal selection and Amplification of Phage Displayed Antibodies by Linking Antigen Recognition and Phage Replication,”Biotechnology, 12:999-1002, 1994.
Farmer et al., “Penetration of β-lactamase inhibitors into the periplasm of Gram-negative bacteria,”FEMS Microbial. Lett., 176:11-15, 1999.
Feilmeier et al., “Green fluorescent protein functions as a reporter for protein localization inEscherichia coli,” J. Bacteriol, 182:4068-4076, 2000.
Georgiou and Valax, “Expression of correctly folded proteins inEsherichia coli,” Curr. Opin. Biotechnol., 7:190-197, 1996.
Georgiou et al., “Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines,”Nat. Biotechnol. 15:29-34, 1997.
Griep et al., “pSKAP/S: An Expression Vector for the Production of Single-Chain Fv Alkaline Phosphatase Fusion Proteins,”Prot. Exp. Purif., 16:63-69, 1999.
Griffiths et al., “Isolation of high affinity human antibodies directly formlarge synthetic repertoires,”EMBO J., 13: 3245-3260, 1994.
Hancock and Wong, “Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane,”Antimicrobial Agents and Chemotherapy, 26:48-52, 1984.
Hawkins et al., “Selection of Phage Antibodies by Binding Affinity,”J Mol. Biol., 226:889-896, 1992.
Helander and Mattila-Sandholm, “Fluorometric assessment of gram-negative bacterial permeabilization,”J. of Applied Microbiology, 88:213-219, 2000.
Higgins et al., “Binding protein-dependent transport systems,&#

Affiliated with

Also associated with

Rating

Isolation of binding proteins with high affinity to ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isolation of binding proteins with high affinity to ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of binding proteins with high affinity to ligands will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2678975